ArticleMaedica2025

Innate Immunity Receptor TLR9 Drives Erythrocyte Cholesterol and Ferroprotin Accumulation in a Glutaminase-Independent Manner. Implications for Metabolic Associated Fatty Liver Disease.

Konstantinos Mimidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.